Cargando…
Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy
Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286928/ https://www.ncbi.nlm.nih.gov/pubmed/33730330 http://dx.doi.org/10.1007/s10554-021-02207-1 |
_version_ | 1783723813530238976 |
---|---|
author | Lewis, Andrew J. M. Rayner, Jennifer J. Abdesselam, Ines Neubauer, Stefan Rider, Oliver J. |
author_facet | Lewis, Andrew J. M. Rayner, Jennifer J. Abdesselam, Ines Neubauer, Stefan Rider, Oliver J. |
author_sort | Lewis, Andrew J. M. |
collection | PubMed |
description | Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine cardiovascular magnetic resonance imaging to precisely measure LV wall thickness in the septum and lateral wall in 764 people with body mass indices ranging from 18.5 kg/m(2) to 59.2 kg/m(2) in the absence of major comorbidities. Obesity was related to LV wall thickness across the cohort (basal septum r 0.30, P < 0.001 and basal lateral wall r 0.18, P < 0.001). Although no participant had hypertension, these associations remained highly significant after controlling for systolic blood pressure (all P < 0.01). Each 10 kg/m(2) increase in BMI was associated with an increase in basal septal wall thickness of 1.0 mm males and 0.8 mm in females, with no statistically significant difference between genders (P = 0.1). Even in class 3 obesity (BMI > 40 kg/m(2)), no LV wall thickness > 13.4 mm in males or > 12.7 mm in females was observed in this cohort. We confirm that obesity in the absence of comorbidities is associated with LV hypertrophy, and establish that the magnitude of this change is modest even in severe obesity. LV hypertrophy > 14 mm cannot safely be attributed to obesity alone and alternative diagnoses should be considered. |
format | Online Article Text |
id | pubmed-8286928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-82869282021-07-20 Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy Lewis, Andrew J. M. Rayner, Jennifer J. Abdesselam, Ines Neubauer, Stefan Rider, Oliver J. Int J Cardiovasc Imaging Original Article Obesity is associated with the development of left ventricular (LV) hypertrophy. Whether obesity in in the absence of comorbidities can cause LV hypertrophy to an extent which could create diagnostic uncertainty with pathological states (such as hypertrophic cardiomyopathy) is unknown. We used cine cardiovascular magnetic resonance imaging to precisely measure LV wall thickness in the septum and lateral wall in 764 people with body mass indices ranging from 18.5 kg/m(2) to 59.2 kg/m(2) in the absence of major comorbidities. Obesity was related to LV wall thickness across the cohort (basal septum r 0.30, P < 0.001 and basal lateral wall r 0.18, P < 0.001). Although no participant had hypertension, these associations remained highly significant after controlling for systolic blood pressure (all P < 0.01). Each 10 kg/m(2) increase in BMI was associated with an increase in basal septal wall thickness of 1.0 mm males and 0.8 mm in females, with no statistically significant difference between genders (P = 0.1). Even in class 3 obesity (BMI > 40 kg/m(2)), no LV wall thickness > 13.4 mm in males or > 12.7 mm in females was observed in this cohort. We confirm that obesity in the absence of comorbidities is associated with LV hypertrophy, and establish that the magnitude of this change is modest even in severe obesity. LV hypertrophy > 14 mm cannot safely be attributed to obesity alone and alternative diagnoses should be considered. Springer Netherlands 2021-03-17 2021 /pmc/articles/PMC8286928/ /pubmed/33730330 http://dx.doi.org/10.1007/s10554-021-02207-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Lewis, Andrew J. M. Rayner, Jennifer J. Abdesselam, Ines Neubauer, Stefan Rider, Oliver J. Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title | Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title_full | Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title_fullStr | Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title_full_unstemmed | Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title_short | Obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
title_sort | obesity in the absence of comorbidities is not related to clinically meaningful left ventricular hypertrophy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286928/ https://www.ncbi.nlm.nih.gov/pubmed/33730330 http://dx.doi.org/10.1007/s10554-021-02207-1 |
work_keys_str_mv | AT lewisandrewjm obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy AT raynerjenniferj obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy AT abdesselamines obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy AT neubauerstefan obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy AT rideroliverj obesityintheabsenceofcomorbiditiesisnotrelatedtoclinicallymeaningfulleftventricularhypertrophy |